rs17056706

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000515337.1(IL12B-AS1):​n.746-3769C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.436 in 152,010 control chromosomes in the GnomAD database, including 15,210 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 15210 hom., cov: 32)

Consequence

IL12B-AS1
ENST00000515337.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.622

Publications

9 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000515337.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.551 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000515337.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12B-AS1
NR_037889.1
n.746-3769C>T
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12B-AS1
ENST00000515337.1
TSL:2
n.746-3769C>T
intron
N/A
IL12B-AS1
ENST00000641150.1
n.325-3769C>T
intron
N/A
IL12B-AS1
ENST00000764988.1
n.567-10257C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.436
AC:
66241
AN:
151892
Hom.:
15187
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.557
Gnomad AMI
AF:
0.397
Gnomad AMR
AF:
0.446
Gnomad ASJ
AF:
0.334
Gnomad EAS
AF:
0.476
Gnomad SAS
AF:
0.464
Gnomad FIN
AF:
0.463
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.359
Gnomad OTH
AF:
0.404
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.436
AC:
66330
AN:
152010
Hom.:
15210
Cov.:
32
AF XY:
0.444
AC XY:
32974
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.557
AC:
23079
AN:
41444
American (AMR)
AF:
0.446
AC:
6813
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.334
AC:
1159
AN:
3466
East Asian (EAS)
AF:
0.476
AC:
2459
AN:
5168
South Asian (SAS)
AF:
0.464
AC:
2237
AN:
4818
European-Finnish (FIN)
AF:
0.463
AC:
4884
AN:
10552
Middle Eastern (MID)
AF:
0.327
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
0.359
AC:
24389
AN:
67968
Other (OTH)
AF:
0.404
AC:
852
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1847
3694
5542
7389
9236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
608
1216
1824
2432
3040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.376
Hom.:
14222
Bravo
AF:
0.441
Asia WGS
AF:
0.443
AC:
1543
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.48
DANN
Benign
0.57
PhyloP100
-0.62

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs17056706;
hg19: chr5-158770755;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.